Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...
Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...
Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...
Cardiology, well into the age of leadless pacemakers, could be headed for an age of leadless pacemaker systems in which various pacing functions are achieved by multiple implants that "talk" to each ...
Patients who received leadless pacemakers experienced fewer short-term and mid-term complications overall than those who had traditional transvenous pacemakers, a Cleveland Clinic-led research study ...
The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of an electrical impulse through the heart begins at the sinoatrial (SA) node and ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...
June 21, 2012 (Nice, France) — The next "disruptive" technology in pacemaker and ICD technology may be devices that do not have any transvenous leads or perhaps no leads at all [1]. The potential for ...
BATON ROUGE, La.- Dr. Robert Drennan, electrophysiologist at CIS, used the leadless pacemaker by Abbott Aveir™ on July 15, at Baton Rouge General Medical in the catheterization laboratory. Dr. Drennan ...
With more self-contained models potentially on their way to patients, the FDA is taking steps to remind healthcare providers of certain risks posed by leadless pacemakers, including the possibility of ...
BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...